Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology.

Figiel S. et al, (2024), Eur Urol

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease.

Charlton PV. et al, (2024), Prostate, 84, 977 - 990

Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics.

Desai TA. et al, (2024), EBioMedicine, 105

Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial.

Marian IR. et al, (2024), Trials, 25

First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy

Hamdy FC. et al, (2024), European Journal of Nuclear Medicine and Molecular Imaging

Perspectives on technology - prostate cancer: is local anaesthetic transperineal prostate biopsy really better than transrectal biopsy?

Berridge C. et al, (2024), BJU Int

Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features.

Rao S. et al, (2024), Genome Med, 16

Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10-year single-centre cohort

Anbarasan T. et al, (2024), BJUI Compass

Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.

Figiel S. et al, (2023), Mol Cancer, 22

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those withde novometastatic disease

Charlton P. et al, (2023)

Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.

Rao SR. et al, (2023), Int J Mol Sci, 24

Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?

Cussenot O. et al, (2023), BJU Int

Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique.

Bryant RJ. et al, (2023), BJU Int, 131, 694 - 704

Re: Fifteen-year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

Sharma AD. et al, (2023), Eur Urol

Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia.

Pratsinis M. et al, (2023), World J Urol, 41, 1125 - 1131

The Detection of Prostate Cancer With Magnetic Resonance Imaging-targeted Prostate Biopsies Is Superior With the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. Letter

Bryant RJ. et al, (2023), Journal of Urology, 209

Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole genome sequencing with histopathological features

Rao SR. et al, (2023)

Total pelvic exenteration surgery for loco-regionally advanced prostate cancer, is it justifiable?

Cussenot O. et al, (2022), BJU International, 130, 582 - 585

Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones.

Marklund M. et al, (2022), Nat Commun, 13

Spatially resolved clonal copy number alterations in benign and malignant tissue.

Erickson A. et al, (2022), Nature, 608, 360 - 367

Load More

1
2
3
4
5
6
7

Include forthcoming?